FDA on rosiglitazone. More on advisory committee decision.
Graham
David J
DJ
Gelperin
Kate
K
D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D017202:Myocardial Ischemia / Q000139:chemically induced*; D000077154:Rosiglitazone; D056737:Safety-Based Drug Withdrawals; D045162:Thiazolidinediones / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone